-
Catalyst Pharmaceuticals Inc. (CPRX $20.02)
- $20.02 P/E (TTM): 11.99X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Catalyst Pharmaceuticals Inc. (CPRX $20.02)
- $20.02 P/E (TTM): 11.99X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX
-
Elevance Health Inc. (ELV $322.24)
- $322.24 P/E (TTM): 13.31X Cap: $71.58B
- View ELV Profile
- View Questions on ELV
Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.
-
Catalyst Pharmaceuticals Inc. (CPRX $20.02)
- $20.02 P/E (TTM): 11.99X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX
Q: Are there any news or downgrades for CPRX? It's down 3.5% on the up day. Do you still like/recommend this stock for healthcare holdings?
-
Catalyst Pharmaceuticals Inc. (CPRX $20.02)
- $20.02 P/E (TTM): 11.99X Cap: $2.45B
- View CPRX Profile
- View Questions on CPRX
Q: Hi 5i Team,
Pls comment on Catalyst Pharmaceuticals quarter earning and this company going forward.
Thanks .
Pls comment on Catalyst Pharmaceuticals quarter earning and this company going forward.
Thanks .
Insiders
Share Information
SEC Filings
News and Media